Daniel Vial brings a wealth of healthcare experience, both as an investor and former pharma executive.
Daniel started his career through the launch of a daily newspaper for doctors : “Le Quotidien du Médecin” in France and “Arzte Zeitung” in Germany. “Le Quotidien du Médecin” merged with the medical arm of the Vivendi Group while “Arzte Zeitung” merged with IMS (now Iqvia).
Subsequently, he founded PR INT, a consultancy dedicated to supporting pharma corporations, medical institutions and scientific associations from drug development to commercialization. PR INTernational become one of the leading global consultants in drug evaluation, pharma marketing issues and market access, as well as one of the largest scientific event organizers in Europe. Daniel joined SANOFI as the special advisor to the CEO, Chris Viehbacher, from 2008 to 2014.
More recently, Daniel, a successful investor in French & US biotech companies, serves as a consultant to pharma, biotech, e-health and institutions with a focus in Asia where he advises public institutions such as regions and cities in China. He is the President of the International committee for the Safeguard of the Great Wall of China.
Daniel holds a Master’s in Marketing and Public Relations from the University of Vincennes.
He is a “Chevalier de la Légion d’honneur”.